BP
ADNT icon

Ballentine Partners’s Adient ADNT Stock Holding History

Ballentine Partners’s Portfolio ADNT Stock Details ADNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$186K Sell
10,106
-901
-8% -$19.3K ﹤0.01% 1015
2026
Q1 		$222K Buy
11,007
+41
+0.4% +$912 ﹤0.01% 888
2025
Q4 		$210K Sell
10,966
-560
-5% -$11.8K ﹤0.01% 904
2025
Q3 		$278K Hold
11,526
– – ﹤0.01% 756
2025
Q2 		$224K Buy
+11,526
New +$170K ﹤0.01% 832

Other funds holding ADNT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.83B AUM 34.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ballentine Partners's ADNT Position: Q2 2026 in Review

Ballentine Partners reduced its Adient (ADNT) stake by 8.2% in Q2 2026, selling an estimated $19.3K and leaving 10,106 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #1015.

Ballentine Partners first reported a position in ADNT in Q2 2025 and has held it in 5 quarters since. The position peaked at $278K in Q3 2025. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Ballentine Partners held 10,106 shares of Adient worth $186K as of Q2 2026.
  • Ballentine Partners sold 901 Adient shares in Q2 2026, an estimated $19.3K.
  • Adient made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #1015 holding.
  • Ballentine Partners first reported a position in Adient in Q2 2025 and has held it in 5 quarters since.
  • Ballentine Partners's Adient position peaked at $278K in Q3 2025.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.